Global Invasive Fungal Infection Supply, Demand and Key Producers, 2024-2030

Description

The global Invasive Fungal Infection market size is expected to reach $ 14230 million by 2030, rising at a market growth of 4.2% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Invasive fungal infection refers to the pathological changes and pathophysiological processes of fungi that invade human tissues and blood, and grow and multiply in them, leading to tissue damage, organ dysfunction, and inflammation.

This report studies the global Invasive Fungal Infection demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Invasive Fungal Infection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Invasive Fungal Infection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Invasive Fungal Infection total market, 2019-2030, (USD Million)
Global Invasive Fungal Infection total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Invasive Fungal Infection total market, key domestic companies and share, (USD Million)
Global Invasive Fungal Infection revenue by player and market share 2019-2024, (USD Million)
Global Invasive Fungal Infection total market by Type, CAGR, 2019-2030, (USD Million)
Global Invasive Fungal Infection total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Invasive Fungal Infection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cidara Therapeutics, Basilea Pharmaceutica, Pfizer, GlaxoSmithKline, Bayer, Abbott, Merck, Astellas Pharma and F2G, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Invasive Fungal Infection market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Invasive Fungal Infection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Invasive Fungal Infection Market, Segmentation by Type
    Diagnosis
    Treatment

Global Invasive Fungal Infection Market, Segmentation by Application
    Yeast-like Fungi
    Filamentous Fungi
    Other

Companies Profiled:
    Cidara Therapeutics
    Basilea Pharmaceutica
    Pfizer
    GlaxoSmithKline
    Bayer
    Abbott
    Merck
    Astellas Pharma
    F2G
    Scynexis
    Associates of Cape Cod
    BioRad
    IMMY
    Beijing Jinshanchuan
    Danna Biological
    Zhanjiang A and C Biological

Key Questions Answered
1. How big is the global Invasive Fungal Infection market?
2. What is the demand of the global Invasive Fungal Infection market?
3. What is the year over year growth of the global Invasive Fungal Infection market?
4. What is the total value of the global Invasive Fungal Infection market?
5. Who are the major players in the global Invasive Fungal Infection market?

Table of Contents

1 Supply Summary
    1.1 Invasive Fungal Infection Introduction
    1.2 World Invasive Fungal Infection Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Invasive Fungal Infection Total Market by Region (by Headquarter Location)
        1.3.1 World Invasive Fungal Infection Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Invasive Fungal Infection Market Size (2019-2030)
        1.3.3 China Invasive Fungal Infection Market Size (2019-2030)
        1.3.4 Europe Invasive Fungal Infection Market Size (2019-2030)
        1.3.5 Japan Invasive Fungal Infection Market Size (2019-2030)
        1.3.6 South Korea Invasive Fungal Infection Market Size (2019-2030)
        1.3.7 ASEAN Invasive Fungal Infection Market Size (2019-2030)
        1.3.8 India Invasive Fungal Infection Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Invasive Fungal Infection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Invasive Fungal Infection Major Market Trends

2 Demand Summary
    2.1 World Invasive Fungal Infection Consumption Value (2019-2030)
    2.2 World Invasive Fungal Infection Consumption Value by Region
        2.2.1 World Invasive Fungal Infection Consumption Value by Region (2019-2024)
        2.2.2 World Invasive Fungal Infection Consumption Value Forecast by Region (2025-2030)
    2.3 United States Invasive Fungal Infection Consumption Value (2019-2030)
    2.4 China Invasive Fungal Infection Consumption Value (2019-2030)
    2.5 Europe Invasive Fungal Infection Consumption Value (2019-2030)
    2.6 Japan Invasive Fungal Infection Consumption Value (2019-2030)
    2.7 South Korea Invasive Fungal Infection Consumption Value (2019-2030)
    2.8 ASEAN Invasive Fungal Infection Consumption Value (2019-2030)
    2.9 India Invasive Fungal Infection Consumption Value (2019-2030)

3 World Invasive Fungal Infection Companies Competitive Analysis
    3.1 World Invasive Fungal Infection Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Invasive Fungal Infection Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Invasive Fungal Infection in 2023
        3.2.3 Global Concentration Ratios (CR8) for Invasive Fungal Infection in 2023
    3.3 Invasive Fungal Infection Company Evaluation Quadrant
    3.4 Invasive Fungal Infection Market: Overall Company Footprint Analysis
        3.4.1 Invasive Fungal Infection Market: Region Footprint
        3.4.2 Invasive Fungal Infection Market: Company Product Type Footprint
        3.4.3 Invasive Fungal Infection Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Invasive Fungal Infection Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Invasive Fungal Infection Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Invasive Fungal Infection Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Invasive Fungal Infection Consumption Value Comparison
        4.2.1 United States VS China: Invasive Fungal Infection Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Invasive Fungal Infection Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Invasive Fungal Infection Companies and Market Share, 2019-2024
        4.3.1 United States Based Invasive Fungal Infection Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Invasive Fungal Infection Revenue, (2019-2024)
    4.4 China Based Companies Invasive Fungal Infection Revenue and Market Share, 2019-2024
        4.4.1 China Based Invasive Fungal Infection Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Invasive Fungal Infection Revenue, (2019-2024)
    4.5 Rest of World Based Invasive Fungal Infection Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Invasive Fungal Infection Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Invasive Fungal Infection Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Invasive Fungal Infection Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Diagnosis
        5.2.2 Treatment
    5.3 Market Segment by Type
        5.3.1 World Invasive Fungal Infection Market Size by Type (2019-2024)
        5.3.2 World Invasive Fungal Infection Market Size by Type (2025-2030)
        5.3.3 World Invasive Fungal Infection Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Invasive Fungal Infection Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Yeast-like Fungi
        6.2.2 Filamentous Fungi
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Invasive Fungal Infection Market Size by Application (2019-2024)
        6.3.2 World Invasive Fungal Infection Market Size by Application (2025-2030)
        6.3.3 World Invasive Fungal Infection Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Cidara Therapeutics
        7.1.1 Cidara Therapeutics Details
        7.1.2 Cidara Therapeutics Major Business
        7.1.3 Cidara Therapeutics Invasive Fungal Infection Product and Services
        7.1.4 Cidara Therapeutics Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Cidara Therapeutics Recent Developments/Updates
        7.1.6 Cidara Therapeutics Competitive Strengths & Weaknesses
    7.2 Basilea Pharmaceutica
        7.2.1 Basilea Pharmaceutica Details
        7.2.2 Basilea Pharmaceutica Major Business
        7.2.3 Basilea Pharmaceutica Invasive Fungal Infection Product and Services
        7.2.4 Basilea Pharmaceutica Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Basilea Pharmaceutica Recent Developments/Updates
        7.2.6 Basilea Pharmaceutica Competitive Strengths & Weaknesses
    7.3 Pfizer
        7.3.1 Pfizer Details
        7.3.2 Pfizer Major Business
        7.3.3 Pfizer Invasive Fungal Infection Product and Services
        7.3.4 Pfizer Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Pfizer Recent Developments/Updates
        7.3.6 Pfizer Competitive Strengths & Weaknesses
    7.4 GlaxoSmithKline
        7.4.1 GlaxoSmithKline Details
        7.4.2 GlaxoSmithKline Major Business
        7.4.3 GlaxoSmithKline Invasive Fungal Infection Product and Services
        7.4.4 GlaxoSmithKline Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 GlaxoSmithKline Recent Developments/Updates
        7.4.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.5 Bayer
        7.5.1 Bayer Details
        7.5.2 Bayer Major Business
        7.5.3 Bayer Invasive Fungal Infection Product and Services
        7.5.4 Bayer Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Bayer Recent Developments/Updates
        7.5.6 Bayer Competitive Strengths & Weaknesses
    7.6 Abbott
        7.6.1 Abbott Details
        7.6.2 Abbott Major Business
        7.6.3 Abbott Invasive Fungal Infection Product and Services
        7.6.4 Abbott Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Abbott Recent Developments/Updates
        7.6.6 Abbott Competitive Strengths & Weaknesses
    7.7 Merck
        7.7.1 Merck Details
        7.7.2 Merck Major Business
        7.7.3 Merck Invasive Fungal Infection Product and Services
        7.7.4 Merck Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Merck Recent Developments/Updates
        7.7.6 Merck Competitive Strengths & Weaknesses
    7.8 Astellas Pharma
        7.8.1 Astellas Pharma Details
        7.8.2 Astellas Pharma Major Business
        7.8.3 Astellas Pharma Invasive Fungal Infection Product and Services
        7.8.4 Astellas Pharma Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Astellas Pharma Recent Developments/Updates
        7.8.6 Astellas Pharma Competitive Strengths & Weaknesses
    7.9 F2G
        7.9.1 F2G Details
        7.9.2 F2G Major Business
        7.9.3 F2G Invasive Fungal Infection Product and Services
        7.9.4 F2G Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 F2G Recent Developments/Updates
        7.9.6 F2G Competitive Strengths & Weaknesses
    7.10 Scynexis
        7.10.1 Scynexis Details
        7.10.2 Scynexis Major Business
        7.10.3 Scynexis Invasive Fungal Infection Product and Services
        7.10.4 Scynexis Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Scynexis Recent Developments/Updates
        7.10.6 Scynexis Competitive Strengths & Weaknesses
    7.11 Associates of Cape Cod
        7.11.1 Associates of Cape Cod Details
        7.11.2 Associates of Cape Cod Major Business
        7.11.3 Associates of Cape Cod Invasive Fungal Infection Product and Services
        7.11.4 Associates of Cape Cod Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Associates of Cape Cod Recent Developments/Updates
        7.11.6 Associates of Cape Cod Competitive Strengths & Weaknesses
    7.12 BioRad
        7.12.1 BioRad Details
        7.12.2 BioRad Major Business
        7.12.3 BioRad Invasive Fungal Infection Product and Services
        7.12.4 BioRad Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 BioRad Recent Developments/Updates
        7.12.6 BioRad Competitive Strengths & Weaknesses
    7.13 IMMY
        7.13.1 IMMY Details
        7.13.2 IMMY Major Business
        7.13.3 IMMY Invasive Fungal Infection Product and Services
        7.13.4 IMMY Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 IMMY Recent Developments/Updates
        7.13.6 IMMY Competitive Strengths & Weaknesses
    7.14 Beijing Jinshanchuan
        7.14.1 Beijing Jinshanchuan Details
        7.14.2 Beijing Jinshanchuan Major Business
        7.14.3 Beijing Jinshanchuan Invasive Fungal Infection Product and Services
        7.14.4 Beijing Jinshanchuan Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Beijing Jinshanchuan Recent Developments/Updates
        7.14.6 Beijing Jinshanchuan Competitive Strengths & Weaknesses
    7.15 Danna Biological
        7.15.1 Danna Biological Details
        7.15.2 Danna Biological Major Business
        7.15.3 Danna Biological Invasive Fungal Infection Product and Services
        7.15.4 Danna Biological Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Danna Biological Recent Developments/Updates
        7.15.6 Danna Biological Competitive Strengths & Weaknesses
    7.16 Zhanjiang A and C Biological
        7.16.1 Zhanjiang A and C Biological Details
        7.16.2 Zhanjiang A and C Biological Major Business
        7.16.3 Zhanjiang A and C Biological Invasive Fungal Infection Product and Services
        7.16.4 Zhanjiang A and C Biological Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Zhanjiang A and C Biological Recent Developments/Updates
        7.16.6 Zhanjiang A and C Biological Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Invasive Fungal Infection Industry Chain
    8.2 Invasive Fungal Infection Upstream Analysis
    8.3 Invasive Fungal Infection Midstream Analysis
    8.4 Invasive Fungal Infection Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Invasive Fungal Infection Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Invasive Fungal Infection Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Invasive Fungal Infection Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Invasive Fungal Infection Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Invasive Fungal Infection Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Invasive Fungal Infection Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Invasive Fungal Infection Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Invasive Fungal Infection Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Invasive Fungal Infection Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Invasive Fungal Infection Players in 2023
    Table 12. World Invasive Fungal Infection Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Invasive Fungal Infection Company Evaluation Quadrant
    Table 14. Head Office of Key Invasive Fungal Infection Player
    Table 15. Invasive Fungal Infection Market: Company Product Type Footprint
    Table 16. Invasive Fungal Infection Market: Company Product Application Footprint
    Table 17. Invasive Fungal Infection Mergers & Acquisitions Activity
    Table 18. United States VS China Invasive Fungal Infection Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Invasive Fungal Infection Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Invasive Fungal Infection Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Invasive Fungal Infection Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Invasive Fungal Infection Revenue Market Share (2019-2024)
    Table 23. China Based Invasive Fungal Infection Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Invasive Fungal Infection Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Invasive Fungal Infection Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Invasive Fungal Infection Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Invasive Fungal Infection Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Invasive Fungal Infection Revenue Market Share (2019-2024)
    Table 29. World Invasive Fungal Infection Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Invasive Fungal Infection Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Invasive Fungal Infection Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Invasive Fungal Infection Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Invasive Fungal Infection Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Invasive Fungal Infection Market Size by Application (2025-2030) & (USD Million)
    Table 35. Cidara Therapeutics Basic Information, Area Served and Competitors
    Table 36. Cidara Therapeutics Major Business
    Table 37. Cidara Therapeutics Invasive Fungal Infection Product and Services
    Table 38. Cidara Therapeutics Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Cidara Therapeutics Recent Developments/Updates
    Table 40. Cidara Therapeutics Competitive Strengths & Weaknesses
    Table 41. Basilea Pharmaceutica Basic Information, Area Served and Competitors
    Table 42. Basilea Pharmaceutica Major Business
    Table 43. Basilea Pharmaceutica Invasive Fungal Infection Product and Services
    Table 44. Basilea Pharmaceutica Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Basilea Pharmaceutica Recent Developments/Updates
    Table 46. Basilea Pharmaceutica Competitive Strengths & Weaknesses
    Table 47. Pfizer Basic Information, Area Served and Competitors
    Table 48. Pfizer Major Business
    Table 49. Pfizer Invasive Fungal Infection Product and Services
    Table 50. Pfizer Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Pfizer Recent Developments/Updates
    Table 52. Pfizer Competitive Strengths & Weaknesses
    Table 53. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 54. GlaxoSmithKline Major Business
    Table 55. GlaxoSmithKline Invasive Fungal Infection Product and Services
    Table 56. GlaxoSmithKline Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. GlaxoSmithKline Recent Developments/Updates
    Table 58. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 59. Bayer Basic Information, Area Served and Competitors
    Table 60. Bayer Major Business
    Table 61. Bayer Invasive Fungal Infection Product and Services
    Table 62. Bayer Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Bayer Recent Developments/Updates
    Table 64. Bayer Competitive Strengths & Weaknesses
    Table 65. Abbott Basic Information, Area Served and Competitors
    Table 66. Abbott Major Business
    Table 67. Abbott Invasive Fungal Infection Product and Services
    Table 68. Abbott Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Abbott Recent Developments/Updates
    Table 70. Abbott Competitive Strengths & Weaknesses
    Table 71. Merck Basic Information, Area Served and Competitors
    Table 72. Merck Major Business
    Table 73. Merck Invasive Fungal Infection Product and Services
    Table 74. Merck Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Merck Recent Developments/Updates
    Table 76. Merck Competitive Strengths & Weaknesses
    Table 77. Astellas Pharma Basic Information, Area Served and Competitors
    Table 78. Astellas Pharma Major Business
    Table 79. Astellas Pharma Invasive Fungal Infection Product and Services
    Table 80. Astellas Pharma Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Astellas Pharma Recent Developments/Updates
    Table 82. Astellas Pharma Competitive Strengths & Weaknesses
    Table 83. F2G Basic Information, Area Served and Competitors
    Table 84. F2G Major Business
    Table 85. F2G Invasive Fungal Infection Product and Services
    Table 86. F2G Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. F2G Recent Developments/Updates
    Table 88. F2G Competitive Strengths & Weaknesses
    Table 89. Scynexis Basic Information, Area Served and Competitors
    Table 90. Scynexis Major Business
    Table 91. Scynexis Invasive Fungal Infection Product and Services
    Table 92. Scynexis Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Scynexis Recent Developments/Updates
    Table 94. Scynexis Competitive Strengths & Weaknesses
    Table 95. Associates of Cape Cod Basic Information, Area Served and Competitors
    Table 96. Associates of Cape Cod Major Business
    Table 97. Associates of Cape Cod Invasive Fungal Infection Product and Services
    Table 98. Associates of Cape Cod Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Associates of Cape Cod Recent Developments/Updates
    Table 100. Associates of Cape Cod Competitive Strengths & Weaknesses
    Table 101. BioRad Basic Information, Area Served and Competitors
    Table 102. BioRad Major Business
    Table 103. BioRad Invasive Fungal Infection Product and Services
    Table 104. BioRad Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. BioRad Recent Developments/Updates
    Table 106. BioRad Competitive Strengths & Weaknesses
    Table 107. IMMY Basic Information, Area Served and Competitors
    Table 108. IMMY Major Business
    Table 109. IMMY Invasive Fungal Infection Product and Services
    Table 110. IMMY Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. IMMY Recent Developments/Updates
    Table 112. IMMY Competitive Strengths & Weaknesses
    Table 113. Beijing Jinshanchuan Basic Information, Area Served and Competitors
    Table 114. Beijing Jinshanchuan Major Business
    Table 115. Beijing Jinshanchuan Invasive Fungal Infection Product and Services
    Table 116. Beijing Jinshanchuan Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Beijing Jinshanchuan Recent Developments/Updates
    Table 118. Beijing Jinshanchuan Competitive Strengths & Weaknesses
    Table 119. Danna Biological Basic Information, Area Served and Competitors
    Table 120. Danna Biological Major Business
    Table 121. Danna Biological Invasive Fungal Infection Product and Services
    Table 122. Danna Biological Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Danna Biological Recent Developments/Updates
    Table 124. Zhanjiang A and C Biological Basic Information, Area Served and Competitors
    Table 125. Zhanjiang A and C Biological Major Business
    Table 126. Zhanjiang A and C Biological Invasive Fungal Infection Product and Services
    Table 127. Zhanjiang A and C Biological Invasive Fungal Infection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 128. Global Key Players of Invasive Fungal Infection Upstream (Raw Materials)
    Table 129. Invasive Fungal Infection Typical Customers
List of Figure
    Figure 1. Invasive Fungal Infection Picture
    Figure 2. World Invasive Fungal Infection Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Invasive Fungal Infection Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Invasive Fungal Infection Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Invasive Fungal Infection Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Invasive Fungal Infection Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Invasive Fungal Infection Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Invasive Fungal Infection Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Invasive Fungal Infection Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Invasive Fungal Infection Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Invasive Fungal Infection Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Invasive Fungal Infection Revenue (2019-2030) & (USD Million)
    Figure 13. Invasive Fungal Infection Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Invasive Fungal Infection Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Invasive Fungal Infection Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Invasive Fungal Infection Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Invasive Fungal Infection Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Invasive Fungal Infection Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Invasive Fungal Infection Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Invasive Fungal Infection Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Invasive Fungal Infection Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Invasive Fungal Infection Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Invasive Fungal Infection by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Invasive Fungal Infection Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Invasive Fungal Infection Markets in 2023
    Figure 27. United States VS China: Invasive Fungal Infection Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Invasive Fungal Infection Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Invasive Fungal Infection Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Invasive Fungal Infection Market Size Market Share by Type in 2023
    Figure 31. Diagnosis
    Figure 32. Treatment
    Figure 33. World Invasive Fungal Infection Market Size Market Share by Type (2019-2030)
    Figure 34. World Invasive Fungal Infection Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Invasive Fungal Infection Market Size Market Share by Application in 2023
    Figure 36. Yeast-like Fungi
    Figure 37. Filamentous Fungi
    Figure 38. Other
    Figure 39. Invasive Fungal Infection Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Cidara Therapeutics
Basilea Pharmaceutica
Pfizer
GlaxoSmithKline
Bayer
Abbott
Merck
Astellas Pharma
F2G
Scynexis
Associates of Cape Cod
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A and C Biological